Number of Shares
2,236.00
Current Holdings Value*
$398,500.00
% of Portfolio
2.88%
Total Estimate Gain
$224,587.19
% of Total Estimate Gain
40.87%

Equity Income Portfolio's Quest Diagnostics Inc Holding Summary

As of 2025-04-30, GLENMEDE FUND INC held 2,236.00 shares of Quest Diagnostics Inc(DGX), totaling $398,500.00. This investment constitutes 2.88% of their stock portfolio, and GLENMEDE FUND INC now holds 0% of the outstanding Quest Diagnostics Inc(DGX) stock.

The initial trade took place in 2019Q4. And since then Equity Income Portfolio has made 3 purchases of DGX, at an average price of $106.14, for a total of 5,177.00 shares. In addition, there have been 15 sales at an average price of $132.51 for 2,941.00 shares. Based on historical transaction data and DGX's current price of $171.90, Equity Income Portfolio's estimated gain on his DGX holdings is $224,587.19, reflecting a 40.87% gain to date.

Equity Income Portfolio DGX ($171.90) Holding Chart

Equity Income Portfolio DGX ($171.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1